Search

Your search keyword '"Anker, S D"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Anker, S D" Remove constraint Author: "Anker, S D" Database OpenAIRE Remove constraint Database: OpenAIRE
75 results on '"Anker, S D"'

Search Results

1. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

2. Multicomponent intervention to prevent mobility disability in frail older adults:randomised controlled trial (SPRINTT project)

3. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

4. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

5. Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

6. The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans

7. Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (Clinical Research in Cardiology, (2020), 109, 3, (331-338), 10.1007/s00392-019-01513-y)

8. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

9. Heart Failure Association of the European Society of Cardiology update on sodium–glucose co-transporter 2 inhibitors in heart failure (an update on the sodium–glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)

10. Effects of serelaxin in patients with acute heart failure

11. Novel endotypes in heart failure: effects on guideline-directed medical therapy

13. A Multicenter, Randomized Study Assessing the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Advanced Heart Failure Patients with Ischemic and Non-ischemic Cardiomyopathy: Interim Results of the AUGMENT-HF Study

14. Ghrelin

15. Ghrelin

16. Ghrelin

17. [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD]

18. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

19. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia

22. Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea Results From the BACH (Biomarkers in Acute Heart Failure) Trial

24. PROCALCITONIN IDENTIFIES ACUTE HEART FAILURE BIOMARKERS IN PATIENTS WITH ACUTE HEART FAILURE IN NEED OF ANTIBIOTIC THERAPY: OBSERVATIONAL RESULTS FROM THE BACH (BIOMARKERS IN ACUTE HEART FAILURE) TRIAL

25. PROCALCITONIN IDENTIFIES ACUTE HEART FAILURE BIOMARKERS IN PATIENTS WITH ACUTE HEART FAILURE IN NEED OF ANTIBIOTIC THERAPY: OBSERVATIONAL RESULTS FROM THE BACH (BIOMARKERS IN ACUTE HEART FAILURE) TRIAL

26. ESPEN Guidelines on Parenteral Nutrition: On Cardiology and Pneumology

37. Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology (vol 22, pg 1315, 2020)

43. Kalp dişi cerrahide preoperatif kardiyak riskin deǧ erlendirilmesi ve perioperatif kardiyak tedaviye ilişkin kilavuzlar

49. Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok

Catalog

Books, media, physical & digital resources